Trial intelligence / Profile preview

Postoperative regional analgesia techniques for elective total knee arthroplasty

ACTRN12616000912482Phase 4Recruiting

Sponsor
Hospital Universitario de Navarra
Start
Jul 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of levobupivacaine, dexamethasone, dexmedetomidine, buprenorphine, bupivacaine and 2 more in postoperative pain and knee osteoarthritis (OA) (10 arms), sponsored by Hospital Universitario de Navarra. Primary endpoint: Pain. Started Jul 2016; status: recruiting.

02

Drugs

levobupivacainedexamethasonedexmedetomidinebuprenorphinebupivacaine
03

Conditions

postoperative painknee osteoarthritis (OA)

Beyond the preview

Go deeper on ACTRN12616000912482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616000912482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call